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Abstract 
The environment of the human body is very aggressive, containing among others bacteria, which contribute to 
the degradation of metal implants. Therefore sometimes implants are covered with nanometals to prevent 
development of aggressive bacteria. This paper deals with implants covered with nanosilver (15nm), which is 
antibacterial. The tested implants included: PE vein implant, an intramedullary implant made of stainless steel  
and  brass implant for tracheotomy. The results showed an appearance of implants covered with silver as 
dependent on the type of bacteria: although silver significantly protected implants against some bacteria, a 
presence of some amounts of Staphylococcus aureus and Staphylococcus epidermidis was noticed after long 
term exposure in the human body. Only single bacteria could be observed on the surface of the tested materials. 
Such behavior is evidence, that silver coatings are effective for different form of materials in the presence of 
various bacteria, however, such behavior is related to form of  bacteria. 
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1. Introduction 
It is well-known, that the insertion of implants into human body carries the risk of bacterial infection, mainly as 
a result of biofilm formation at the implant surface. The first step to form the biofilm is bacteria adhesion. 
Biofilm is a surface-attached aggregates of microorganisms embedded in an  extracellular polysaccharide 
matrix. Biofilm forming bacteria act as efficient barriers against antimicrobial agents and the host immune 
system, resulting in a persistent colonization and/or infection at the site of the biofilm formation. Bacteria living 
within the biofilm structure are more difficult to be destructed by immunity system, as well as are more resistant 
to antibiotics and may cause general body infection in case of weak immunity resistance.   
The silver is known for a long time as a biologically active compound preventing biofilm formation [1]. Such 
efficiency was shown for stainless steels [2,3], Ti and its alloys [4], TiNi alloys [5] and polymers [6]. It was 
used for antibacterial protection for some medical devices [7-9]. 
It is uncertain, whether Ag nanoparticles or Ag+ ions are responsible for the antibacterial action. Silver ions 
were more toxic to E. coli, than nanosilver [10]. Hatchett and White [11] proposed a synergistic toxic effect of 
the silver nanoparticles and the silver ions, which they produce. The ions moved into the cells and lead to the 
production of reactive oxygen species. The potency of Ag as an anti-bacterial coating was suggested to be 
dependent on its biologically active form, soluble Ag ions or Ag clusters, to interfere with the integrity of the 
bacterial cells [12] and to bind to the enzymes and proteins within the bacteria [13,14]. Ag film deposited by 
magnetron sputtering was reported to be in the form of Ag nanocrystalline clusters [15,16]. For the TiNiAg 
alloy immersed in a body fluid, the release of ionized Ag into the surrounding fluid was postulated [5]. The 
critical level for the antibacterial efficiency of Ag was very low and has been estimated at 0.1 ppb [17] or 0.5 
ppb [18].  
According to Navarro et al. [19] nanosilver can impart toxicity in both ion and particle forms, and silver ions 
were more toxic to E. coli, than nanosilver. Nanoparticle toxicity is size dependent with smaller size particles 
presenting higher toxicity [20-23].  The release rate and an effective killing time can be 15 days [4] and in case 
of silver inside the oxide nanotubes the bacterial adhesion is maintained without obvious decline for 30 days, 
which are normally long enough to prevent post-operation infection in the early and intermediate stages and 
perhaps even late infection around the implant [24]. In other work [25] the Ag effective concentration was at 
least 0.06 mM, and in 0.02 mM the antibacterial ratio to Staphylococcus aureus decreased to 63.30% [25].   
AgNPs due to the wide spectrum of antimicrobial activity pay particular attention in contemporary orthopedics 
and bone and tissue engineering. However, still unexplained information about AgNPs-induced cytotoxicity in 
mammalian cells limited their use in tissue repair. It was demonstrated that exposure to AgNPs leads to an 
increase of oxidative stress, apoptosis and genotoxicity in cultured cells and animal tissues [26]. Interestingly, it 
was found that co-exposure of human gingival fibroblast cells to AgNPs and fluoride resulted in enhancing of 
cytotoxic damage [27]. Also, contradictory results are found in an available literature.  Hackenberg et 
al.[28]  observed a decrease in human mesenchymal stem cell after 1 h treatment with  AgNPs <50 nm at 
concentration of 10 μg/mL. On the other hand, Samberg et al.[29] observed no toxicity for progenitor human 
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adipose-derived stem cells exposed to up to 100 μg/mL AgNPs with size 10 and 20 nm for 24 h.  Therefore, in 
our study we decided to assess the impact of commercially available AgNPs with size 15 nm on human 
osteoblast cells viability.  
The silver can be effective against different forms of bacteria for different materials. Even, if this role of silver is 
well known, less is known about selective biological activity and strength of silver in the presence of many 
different bacteria, which may together and in different contents appear in dangerous and frequent clinical 
inflammations. For the  Ti-6Al-4V alloy such ability was observed against Staphylococcus epidermidis  [4], 
against, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus with more than 90% antibacterial 
ratio [25], against the Staphylococcus epidermidis and Staphylococcus aureus [30].  
The composition and structure of surface for Ag deposition is also important even, if this effect is moderate. 
Different solutions were postulated and investigated. The Ag deposited on PE showed almost 100% anti-
bacterial ability [6]. Another tested form is the Ag particles dispersed within the titanium oxide obtained by 
anodic spark deposition in an aqueous electrolyte on the medical grade Ti-6Al-4V alloy, as small particles of 
sizes below 200 nm [4]. The next implementation technique for Ag ions based on a immersion of vacuum 
plasma sprayed titanium coatings in Ag+ containing calcification solution [25]. TiO2-capped Ag nanorods can 
be also applied as a lasting and strong antibacterial material with controll-ability of the silver ion release through 
the mesoporous and aqueous cap layer. Mesoporous TiO2 cap layer is controlled the water and silver inter-
diffusion [31]. Three kinds of antibacterial ingredients were loaded into the hydroxyapatite (HA) coating: 
antibiotic (Ampicillin sodium salt), silver ions and water soluble chitosan. The coatings with a porous structure 
showed improved antibacterial properties, likely due to better loading and more sustained release of the 
antibacterial ingredients, except for the highly water-soluble antibiotics [32]. Recently, nanosilver cement also 
proved to possessed high-antibacterial activity against multiresistant bacteria, including methicillin-resistant S. 
epidermidis(MRSE), and methicillin-resistant S. aureus (MRSA), and free of in vitro cytotoxicity [33]. The 
synthesized Ag–TiO2/(a)TiO2 nanocomposite thin film can be utilized as a promising and effective bactericidal 
material in the future [34]. The interesting research on four types of silver coatings with various surface energies 
prepared on stainless steel plates using AgNO3 based on electroless plating solutions showed, that bacterial 
adhesion decreased with the total surface energy of the coatings decreasing, but also decreased with the electron 
donor component increasing [2]. Micro-electrochemical cells and galvanic effects between Ag nanoparticles and 
Ti matrix play an important role in the interactions with the attached cells supporting the direct deposition of 
silver inside the titanium [35]. Titania nanotubes (TiO2-NTs) incorporated with silver (Ag) nanoparticles can be 
fabricated on Ti implants to achieve this purpose. The Ag nanoparticles adhere tightly to the wall of the TiO2-
NTs prepared by immersion in a silver nitrate solution followed by ultraviolet light radiation. The amount of Ag 
introduced to the NTs can be varied by changing processing parameters such as the AgNO3 concentration and 
immersion time. In the last years the increasing interest in loading of nanosilver into the oxide nanotubes can be 
noticed with long term biological efficiency [24]. The silver can be also introduced into hydroxyapatite coatings 
by coprecipitation or plasma spraying. Both coatings can slowly release silver nanoparticles and Ag + ions in 
simulated body fluids [36]. Such solutions presumably made the coatings exhibit a good anti-bacterial effect. 
The bioactivity of the first solution is claimed to be higher, than the last one.  
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Even of the antimicrobial effect of silver ions has been studied extensively, the effects of silver on bacteria and 
the bactericidal mechanism are not fully understood. Bacteria affected by nanosilver cannot breathe, because the 
transfer of electrons in a cell is destroyed. Silver prevents metabolic reactions in a bacteria cell, because it reacts 
with the –SH enzyme groups [37]. The silver nanoparticles anchor to and penetrate the cell wall of Gram-
negative bacteria [38,39]. It might be assumed, that the resultant structural change in the cell membrane could 
cause an increase in cell permeability, leading to an uncontrolled transport through the cytoplasmic membrane 
and ultimately cell death. The antibacterial mechanism of silver nanoparticles may be also related to the 
formation of free radicals and subsequent free radical-induced membrane damage [40,41]. However, no damage 
by silver ions was postulated by Hwang et al. [42]. The silver nanoparticles may modulate the phosphor-tyrosine 
profile of putative bacterial peptides, that could affect cellular signaling and therefore inhibit the growth of 
bacteria [43]. Silver and copper can cause bacterial inactivation in vitro by binding to microbial DNA, 
preventing bacterial replication, and disrupting the sulfhydryl groups of metabolic enzymes in the bacterial 
electron transport chain [30,44-46].  
Silver is a metal, that may in excess cause some detrimental effects. The toxic effects of silver substances are 
proportional to the rate of release of free silver ions from them [35]. The silver nanoparticles may interact with 
proteins and enzymes with thiol groups within mammalian cells. Then apoptogenic factors like cytochrome C 
are released and programmed cell death is a final result. Besides mitochondrial destruction, damage to cell 
membranes appears to be another part of nanosilver’s mechanism of cytotoxicity, that precedes mitochondrial 
perturbation [47-50]. Silver ions released from nanosilver may react with the microbial membrane and inactivate 
cell functions, while small particles may enter the cells to disrupt microbial metabolism, making nanosilver 
highly toxic [21-23]. Therefore, the toxicity of nanosilver may be controlled by particle size (cell internal-
ization), Ag release rate (particle stability), and surface characteristics (e.g., surface film formation). The first 
evidence for a cell-type-specific uptake of Ag-NP by peripheral blood mononuclear cells (PBMC) and the 
resultant cellular responses after exposure.  
The research was aimed at verifying, whether a silver coat already developed effectively as antibacterial 
protection against  different kinds of  bacteria together, which may appear under hospital conditions. The objects 
of research included implants applied at hospital conditions: vein implant, steel implant and brass pipe for 
tracheotomia. The purpose for this experiment is an assumption, which if any antibiotic may be helpful to a 
single group of bacteria, silver ions or nanosilver clusters may be effective against a wide range of bacteria. 
Even, if usually the hospital inflammations occur, because of a presence of a single bacteria and can be 
prevented or cured with antibiotics, silver or nanosilver may substitute or accompany the traditional treatment. 
The second objective of this work is to contribute into explaining the exact mechanism of silver antibacterial 
action. 
2. Materials and research methods 
Three specific implants for investigations included: (i) polymer (polyethylene) vein implants covered with silver 
(the amount of silver ranged from 0.07 to 0.16 mg/cm2), i.e.  SILVER GRAFT (Figure 1); (ii)  intramedullary 
nail for long bones made of stainless steel (17.57Cr, 14.29Ni, 5.66 Mo), covered with silver (average size of 
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nanoparticles of silver were 40 nm) by PVD method (Figure 2); (iii) brass pipe (64Cu, 34Zn, 0.8Pb, 0.05Al, 
0.1Fe, 0.3Ni, 0.1Sn) for tracheotomy covered with silver on the outer side by PVD method (average size of 
nanoparticles of silver were 40 nm) (Figure 3). All implants were made by the Aesculap Chifa Ltd., Poland; the 
chemical composition is according to the supplier`s specification.  
 
Figure 1: Antibacterial vein implant SILVER GRAFT covered with silver [51] 
 
Figure 2: The intramedullary nail covered with silver [51] 
 
Figure 3: The pipe used for tracheotomy [51] 
All implants were cut for the tests into pieces of 10x15 mm. For the products the steam sterilization was 
performed in an autoclave, at a pressure of 0.2 MPa and temperature 1340C for 10 min.   
Simultaneously the research of cythotoxicity on human osteoblasts was carried out. 
AgNPs (size 40 nm) water dispersion were purchased from MK Nano Company. 
Human fetal osteoblast cell line (hFOB 1.19) was obtained from the American Type Culture Collection 
([ATCC], Manassas, VA, USA) and maintained as a monolayer culture in T-75 cm2 flasks. The cells were 
grown in a mixture of Dulbecco’s Modified Eagle’s Medium and Ham Nutried Mixture (Sigma-Aldrich)  
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containing sodium pyruvate (110 mg/L) and supplemented with 10% fetal bovine serum, 6 μg/mL penicillin-G, 
and 10 μg/mL streptomycin. Cells were maintained at 37°C in a humidified atmosphere of 95% O2 and 5% 
CO2. hen confluent, cells were detached enzymatically with trypsin-EDTA and sub-cultured into a new cell 
culture flask. The medium was replaced every 2 days. These hFOB cells were indicated to be an excellent model 
system for the study of osteoblast biology in vitro. 
Human fetal osteoblast cell line (hFOB 1.19) were treated with 40 nm AgNPs (1-80 μg/mL) for 24 hours. The 
dilutions of AgNPs were prepared just before adding to the cells in fetal bovine serum-free (SF) culture 
medium. AgNPs solutions were vortexed for 1 minute to prevent aggregation following the manufacturer’s 
instructions. Control was cells untreated with AgNPs. 
Cell viability was measured by MTS assay. The hFOB 1.19 cells were seeded triplicate at a density of 
104 cells/100 μL of cell-culture medium into a 96-well plate. The following day, the hFOB 1.19 cells were 
treated with AgNPs as specified in section Treatments. Mitochondrial activity assay (MTS) evaluates 
mitochondrial activity (assesses cell growth and cell death) based on mitochondrial dehydrogenase enzyme's 
ability to convert the tetrazolium salt (MTS) to formazan - a colored reaction product. MTS assay was 
performed by adding a premixed optimized dye reagent to culture wells. Absorbance was read at 450 nm 
(reference: 630 nm) Absorbance values were also corrected with blank NPs. Treated-cell viability was 
calculated and expressed as a percentage (%) of the viability of control cells (100%) based on mean absorbance 
values at 450 nm. 
The examinations of surfaces after exposure were made with the scanning electron microscope Philips XL 30 to 
qualitatively assess the bacteria presence and possible surface degradation. 
3. Results 
In the research, we analyzed the effect of AgNPs (size 40 nm) on the viability of hFOB 1.19 cells. It was found 
that 24 hours treatment of osteoblast cells with AgNPs at a concentration of 1, 5, 10, 20 μg/mL did not cause 
statistically significant changes in cells viability. This range of concentration AgNPs was not cytotoxic to hFOB 
1.19. Nevertheless, under higher concentrations: 40-80 μg/mL AgNPs, a significant decrease of cells viability 
was observed (Figure 4). AgNPs in this concentration range exhibited a cytotoxic effect on hFOB 1.19 cells. 
AgNPs (40 nm) induced death of  hFOB 1.19 cells after 24 h exposure. Data are presented as the means ± SE 
for at least three independent results, analyzed by One-way ANOVA combined with Tukeys Multiple 
Comparison Test. *p<0.05; **p<0.01; ***p<0.001 AgNPs-treated cells versus control (untreated cells). 
The major novel finding of this study is that AgNPs at low concentration ( 1-20 μg/mL) does not cause 
impairment of cell viability. Higher concentration of AgNPs (40-80 μg/mL) significantly decreases the viability 
of human fetal osteoblasts cells. 
For the vein implant (Figure 5) only separate bacteria were observed - Staphylococcus aureus and 
Staphylococcus epidermidis (Figure6).  
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Figure 4: Induction of cell death of hFOB 1.19 cells treated with AgNPs (40 nm) 
 
Figure 5: The surface of the vein implant 
 
Figure 6: The separate bacteria among the fibers of the vein implant -  Staphylococcus aureus and 
Staphylococcus epidermidis 
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The results of microscopic examinations of the intramedullary nail implant covered with silver are presented in 
Figure 7. which shows no noticeable changes in the area covered with silver appeared.   
 
Figure 7: The surface of the intramedullary nail covered with silver 
Figure 8 shows the brass pipe for tracheotomy. After cleaning the surface with Octanisept no degradation was 
noticed.  
 
Figure 8: The surface of the pipe for tracheotomy 
4. Discussion 
The bacteria gather not only on the surface of body cells. Owing to their adhesive properties, they stuck to 
different kinds of materials. The great challenge for contemporary medicine is the formation of biofilms on 
biomaterials. Despite the efforts to obtain a smooth surface of biomaterials, the microscopic analysis shows, that 
the surface is rough, which makes it more accessible for bacteria adhesion. In a few seconds of contact with  
biological fluids, it covers the surface with proteins. The cells contained in body liquids or tissues immediately 
recognize the surface of the implants as a “strange body”. It results in the formation of biofilm.  
The formation of the biofilm aims at the protection of microorganisms (creating biofilm) against degradation 
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activity of environmental factors, including antibiotics. The biofilm is responsible for long lasting diseases, 
especially infections caused by using drains and inserting implants. It is an undesirable problem in hospital 
infections. The complicated structure of the biofilm and various features of microorganisms, which constitute it, 
explain their high resistance to different kinds of fighting their factors, including antibiotics. A biofilm is not 
just a simple layer of slime but a complex multicellular community. Bacteria form biofilms to exploit their 
environment and protect themselves from their hosts. 
This is likely the first attempt to examine the behavior of various bacteria altogether, which might appear on the 
surface of an implant during inflammation process. Such a case may always occur as a consequence of not fully 
aseptic implant and chirurgical instruments, improper conditions at a hospital and even in a surgery room, no 
knowledge of either of a patient or a medical team on the presence of some bacteria in a body. As it is then 
impossible to eliminate totally a risk of bacteria-related inflammation and then a danger of rejection of an 
implant, it would be useful to look for further prevention measures, rather than general and not specific activity. 
These results demonstrate, a little surprisingly, that silver itself, in amounts usually used and allowed, may be 
effective against some different bacteria. There are many reports, citied above, that silver may be valuable for 
killing or preventing Acinetobacter, Bacillus, Clostridium, Enterococcus, Escherichia coli, Klebsiella 
pneumonia,  Listeria, Pseudomonas aeruginosa, P. gingivalis,  Salmonella, Staphylococcus aureus, 
Staphylococcus epidermidis,   Streptococcus and Vibrio, but not all of them together. That means, that this 
biometal is more effective, than antibiotics when placed on a surface of an implant. 
The patients with silver coated implants do not need any additional antibiotic treatment. Such behavior may be 
evidence, that silver is highly harmful and kills almost all bacteria at applied amounts and released rates.  
The mechanism of protection is not fully clear. For one side, it may be selective adhesion of nanoclusters or 
single atoms to the bacteria making their supply with oxygen impossible. On the other hand, almost equal 
effects on different forms of bacteria may suggest rather physical, than chemical explanation, i.e. by making an 
adhesion of bacteria to the surface impossible or very difficult; only bacteria present on the surface and not in 
the liquid volume were detected.  
It seems, that the antibacterial property of silver is not directly related  to size of silver particles. It is not then or 
at least it has been never proved, that silver nanoparticles themselves have a so outstanding surface, because of 
their small size and likely unsaturated chemical bonds. We think, that silver in both of micro- and nanometric 
size may be efficient, related to the release rate of silver ions, which are fully responsible for preventing effects. 
However,  nanoparticles have a much more developed surface, so that they may produce significant amounts of 
silver ions and in such a way demonstrate a great potential. Such model explains, why both nanoparticles and 
silver ions possess an antibacterial efficiency and why the positive effect of decreasing particle size is observed. 
The model shows, that the future research should take into account the release rate of silver ions, both for nano- 
and microcoat, and time to reach the lowest critical concentration sufficient to be active in killing the bacteria, 
which are related to the possible form of attachment of silver to an implant – as a coating, a part of composite 
coating or of oxide nanotubes in Ti and its alloys, etc [31].  
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Similarly to our findings,  Pauksch et al. [52] indicated, that therapeutical window for the use of AgNPs in 
orthopedic products exist. They demonstrated, that AgNPs induced impairment of osteoblast cell viability at 
higher concentrations.  Albers, at al. [53] observed that AgNPs with size 50 nm exhibited strong cytotoxic 
effects on osteoblast. Importantly, they noticed,  that antibacterial effects occurred at AgNPs concentrations, 
which were 2-4 times higher, than those exerting cytotoxic effects. It was also shown, that the adipogenic and 
osteogenic differentiation of human mesenchymal stem cells was impaired even at subtoxic concentrations of 
AgNPs. Importantly, Qin et al. [54] found, that 20 nm AgNPs are induced osteogenic differentiation of urine-
derived stem cells advance osteogenetic differentiation at noncytotoxic concentrations after exposure for 24 
hours. Samberg et al. [29] observed, that treatment with 10 and 20 nm AgNPs did not affect the differentiation 
of the human adipose-derived stem cells and at antimicrobial concentrations of AgNPs induced a minimal 
decrease in viability.  
5. Conclusions 
The silver coatings are almost equally effective against different forms of bacteria, whatever base for their 
deposition, stainless steel, brass or PE is used. 
The mechanism of the antibacterial efficiency of silver against bacteria may involve either a direct killing of 
bacteria by stopping the delivery of oxygen or preventing the adhesion of bacteria on an implant surface. 
The effect of Ag may be observed for both micro- and nanoparticles, with the latter more effective, because of 
the more developed geometric surface; whatever way, Ag ions are responsible for the antibacterial activity. 
The AgNPs exert a cytotoxic effect on human osteoblast cell in a concentration-dependent manner a 
concentrations in the range of 1–20 µg/mL  do not adversely affect the human fetal osteoblast cells viability and 
can be used as antimicrobial additives in implants. However, higher concentrations of AgNPs (40-80 μg/mL) 
should be thoroughly tested and optimized, because it may possess cytotoxic effect against hFOB 1.19 cells.  
More research has to be performed to assess the effects of different AgNPs on bone cells and their usage in 
orthopaedic surgery and tissue engineering. 
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